Fibrate/Statin Initiation in Warfarin Users and Gastrointestinal Bleeding Risk Hedi Schelleman, PhD, Warren B. Bilker, PhD, Colleen M. Brensinger, MS, Fei Wan, MS, Yu-Xiao Yang, MD, MSCE, Sean Hennessy, PharmD, PhD The American Journal of Medicine Volume 123, Issue 2, Pages 151-157 (February 2010) DOI: 10.1016/j.amjmed.2009.07.020 Copyright © 2010 Elsevier Inc. Terms and Conditions
Figure Association between initiation of each antihyperlipidemic agent (exposed versus unexposed) and hospitalization for gastrointestinal bleeding in chronic warfarin users. Each diamond represents the odds ratio of interest, and the vertical line represents the 95% confidence interval. The data are presented on the log scale. All analyses are adjusted for age, sex, race, state, prior gastrointestinal bleed, diabetes, and number of prior warfarin prescriptions filled on the index date. The American Journal of Medicine 2010 123, 151-157DOI: (10.1016/j.amjmed.2009.07.020) Copyright © 2010 Elsevier Inc. Terms and Conditions